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FINAL EXAMINATION DURATION 
PHA406 – Therapeutics B 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has 3 (A, B and C) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions on the Faculty/School 
supplied Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20).  Suggested time allocation: 
One (1) hour. 
Section B contains Five (5) Extended-Answer Questions.  Answer any Four (4) questions only in the 20-
page Booklet provided.  Total marks allocated: Forty (40).  Suggested time allocation: One (1) hour. 
Section C contains Two (2) Case Studies. Answer all Two (2) case studies in the 20-page Booklet 
provided. Total marks allocated: Forty (40).  Suggested time allocation: One (1) hour.    




This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
Answer on the supplied examination material/s only 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
No additional printed material is permitted 1 x 20 Page Book 
Faculty/School Multiple Choice Answer Sheet 
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Section A 
Multiple Choice Questions 
Total No of Marks for this section: 20 
 
 
The answers for this section should be written on the 100-MCQ Answer Sheet provided.  Please 
ensure that your name and student number have been written on the Answer Sheet. 
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Section B 
Extended-Answer Questions 
Total No of Marks for this section: 40 
 
This section should be answered in the 20-page Answer Booklet provided. 
Answer any FOUR (4) questions only. 
 





Question 1 (multiple topics) 
a) Briefly describe the pathophysiology of Central Diabetes Insipidus and discuss the 
therapeutic agents available for the treatment of this condition.  Include in your answer 
the mechanism(s) of action of these agents and any adverse effects, contraindications 
and precautions when using these agents. 
 (5 marks) 
b) Describe THREE (3) different classes of commonly used pharmacological agents for 
the treatment of primary open angle glaucoma (POAG).  Include in your answer the 
mechanisms of action of these agents in reducing intraocular pressure, and any adverse 
effects. 





Question 2 (multiple topics) 
a) Discuss the pathogenesis of ascites and suggest TWO (2) appropriate treatments 
(surgical or pharmacological) which can be used to manage ascites. 
 (5 marks) 
b) Explain the difference(s) between Cushing’s disease and Cushing’s syndrome and 
discuss how they can be treated or managed. 




THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM 
ANY EXAMINATION VENUE IN ANY CIRCUMSTANCE 
 
Semester 1, 2015 FINAL EXAMINATION 
 PHA406 – Therapeutics B 
Page 4 of 20   
 
Question 3 (multiple topics) 
a) How does levodopa/benserazide act to benefit a patient suffering from Parkinson’s 
disease?  What are the advantages and limitations of this combination? 
 (5 marks) 
b) Briefly describe the signs and symptoms of schizophrenia and discuss the advantages of 
using atypical over typical antipsychotics.  Give examples. 




Question 4  
Discuss the pathogenesis, clinical presentation and management plan for bipolar depression.  
How does this differ from unipolar depression? 





Question 5 (multiple topics) 
a) Describe the metabolism of alcohol in the liver and use this to explain the pathogenesis 
of cirrhosis. 
 (5 marks) 
b) Discuss the treatment/management plan(s) for patients suffering from hyperthyroidism.  
Include in your answer the mechanisms of action of agents used to relieve 
hyperthyroidism and associated symptoms. 




E n d  o f  S e c t i on  B  
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Section C 
Case Studies 
Total No of Marks for this section: 40 
 
This section should be answered in the 20-page Answer Booklet provided. 
Answer ALL TWO (2) questions. 
 
Marks for each section are indicated.  Suggested time allocation for Section C: 60 mins 
 
 
Question 1 (20 marks) 
Mr CH, an 83-year-old man, has been living a relatively independent life in a remote area.  
He is still actively involved in his local sport club, goes lawn-bowling with his friends and 
attends social functions on occasion. 
Mr CH noticed some blood on the toilet paper after his regular bowel habit one morning and 
went to see his doctor.  He also complained of tiredness, increasing forgetfulness, feeling 
“sad or down” and believes “he is going to die soon”. 
 
 
Mr CH’s medical history includes: 
Diverticulitis Reflux oesophagitis 
Osteoarthritis Parkinson’s Disease 
Benign Prostatic Hyperplasia Ischaemic Heart Disease 
 
 
His current medications (in a webster pack) include: 
Omeprazole 20mg bd Simvastatin 80mg nocte 
Prazosin 1mg bd Atenolol 25mg mane 




1 tds Panadol Osteo ii tds (he does 
not like it and 
only takes that 
when his 
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His laboratory test results are: 
U&E  Reference 
Range 
Full blood Examination Reference 
Range 
Na+ 132mmol/L 135-145 Hb 110g/L 130-180 
K+ 3.4mmol/L 3.4-4.5 RCC 3.4×1012/L 4.5-6.5 
Cl- 87mmol/L 95-110 Haematocrit 0.38 0.40-0.54 




Creatinine 93µmol/L 60-120 Platelet 480×109/L 150-400 
eGFR 67mL/min/1.73m2 >90 WCC 8.11×109/L 4.0-11.0 
   Neutrophil 5.81×109/L 2-7.5 
LFT  Others  
ALT 9units/L <35 TSH 7.1mIU/L 0.4-5 
AST 43units/L <40 Free T4 13picomol/L 10-25 
ALP 112units/L 25-100    
GGT 137units/L <50    
Albumin 24g/L 32-45    
 
 






Please turn over for questions 
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a) Considering the likely causes of Mr CH’s current clinical presentations and complaints, 
suggest THREE (3) potential diagnoses.  Include in your answer, explain and justify 
your suggestions. 
 (6 marks) 
b) Briefly describe the development of vascular dementia in Mr CH.  Identify and explain 
which of the presenting signs and symptoms are associated with his dementia. 
 (5 marks) 
c) Briefly discuss Mr CH’s laboratory test results.  What are they indicating? 
 (3 marks) 
d) Outline a management plan you would recommend to treat Mr CH’s conditions.  Justify 
your recommendations. 









Please turn over for Case Study 2 
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Question 2 (20 marks) 
Mrs BY is a 56-year-old female who lives with her husband.  Their children live in the 
surrounding suburbs with their own family.  Mrs BY was diagnosed with schizophrenia more 
than 30 years ago and she has been treated with the same drug (trifluoperazine) ever since 
with a reasonably good outcome. 
In the last few days, Mrs BY has been behaving strangely.  She appears to be more easily 
agitated and socially withdrawn.  She also constantly talks about people or incidents that her 
husband does not recognise or recall, and this really upsets him a lot. 
Mrs BY presented to her doctor one morning, accompanied by her husband, after she 
experienced acute distress/aggression the night before.  She also suffered urinary 
incontinence. 
Mrs BY is 170cm in height and weighs 78kg.  She has no known drug allergy. 
Mrs BY’s medical history includes: 




Alcoholism (but claims she has reduced 




Her regular medications include: 
Perindopril  10mg d Trifluoperazine  5mg bd 
Movicol (laxative) ii mane Temazepam  10mg nocte 




Aspirin  100mg d Salbutamol MDI  100mcg prn 
Hiprex (lowers urine 
pH to prevent urinary 
tract infection) 
1g d Clonazepam  1mg prn 
 
On examination, Mrs BY appears agitated but all her other vital signs are relatively normal: 
HR = 97 bpm; Respiratory Rate = 21 breathe per minute; BSL (random) = 7.6mmol/L 
The initial diagnosis for Mrs BY is acute schizophrenia, with or without delirium. 
 
Please turn over for questions 
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a) Other than anxiety disorder, suggest THREE (3) most likely causes/diagnoses of Mrs 
BY’s current complaints.  Explain your answer with reference to Mrs BY’s risk factors 
and clinical presentations. 
 (6 marks) 
b) Identify and discuss the diagnostic tests or examination tools which can be used to 
confirm or exclude the diagnoses you have suggested in a). 
 (6 marks) 
c) Outline the immediate and long-term management plans you would recommend for 
treating Mrs BY’s conditions.  Justify your recommendations. 










E n d  o f  S e c t i on  C  
 
E n d  o f  E xa m  P ap e r  
 
 
 
 
